🏛

Janssen Pharmaceutica

Public profile
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceuticals was purchased by New Jersey–based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), later renamed to Janssen Research and Development, LLC (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.
✏️ Suggest a correction

Spot something wrong? Edit the fields — changes go live immediately and are logged for audit.

📡 Recent posts· 0
No posts pulled in yet. Add where this person/organization posts below, and the platform starts pulling in new posts.
Where they post
No outlets set yet.

📚 Books · 0

No books tagged yet.

🎥 Playlists featuring Janssen Pharmaceutica · 0

No video playlists curated about Janssen Pharmaceutica yet.

Sign in to add a playlist. It surfaces here, on your personal playlists page, and on every twin course at every school.

📺 Videos

· searching YouTube…

Searching YouTube for recent videos about Janssen Pharmaceutica… know one? Suggest it below.

➕ Suggest a YouTube video

Your suggestion appears immediately for all visitors. Must be a public YouTube video relevant to Janssen Pharmaceutica.

Recent news about Janssen Pharmaceutica · 6 · Google News

Headlines from Google News for Janssen Pharmaceutica. Clicking opens the original source.

Quotes· 0

No quotes tagged yet.

⭐ Reviews · 0

No reviews yet. Be the first.

Replies ingeneral· 0

Every shadow page is its own thread. Add a thought, reply to others, come back later.

No comments yet. Be the first.